These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma. Wang Y; Wu J; Xu J; Lin S Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272 [TBL] [Abstract][Full Text] [Related]
3. The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma. Wu Z; Cheng H; Liu J; Zhang S; Zhang M; Liu F; Li Y; Huang Q; Jiang Y; Chen S; Lv L; Li D; Zeng JZ J Hepatocell Carcinoma; 2022; 9():141-155. PubMed ID: 35300206 [TBL] [Abstract][Full Text] [Related]
4. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters. Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310 [TBL] [Abstract][Full Text] [Related]
5. Stanniocalcin-2 expression in glioblastoma - A novel prognostic biomarker: An observational study. Aydin AA; Yildirim S Medicine (Baltimore); 2024 Jul; 103(28):e38913. PubMed ID: 38996177 [TBL] [Abstract][Full Text] [Related]
6. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. Lin S; Guo Q; Wen J; Li C; Lin J; Cui X; Sang N; Pan J J Exp Clin Cancer Res; 2014 Mar; 33(1):26. PubMed ID: 24606961 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of STC2 in colorectal cancer and its clinicopathological significance. Zhang C; Chen S; Ma X; Yang Q; Su F; Shu X; Xie W; Feng M; Xiong B Onco Targets Ther; 2019; 12():1249-1258. PubMed ID: 30863092 [TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer. Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502 [TBL] [Abstract][Full Text] [Related]
9. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study. Aydin HA; Toptas T; Bozkurt S; Aydin A; Erdogan G; Pestereli E; Simsek T Pathol Oncol Res; 2019 Apr; 25(2):751-757. PubMed ID: 30661222 [TBL] [Abstract][Full Text] [Related]
10. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma. Li J; Yang Z; Huang S; Li D Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031 [TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
12. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma. Wu Y; Li X; Chen M; Liu Z; Zhang X; Zheng S; Xu X Oncol Lett; 2021 Mar; 21(3):177. PubMed ID: 33574916 [TBL] [Abstract][Full Text] [Related]
15. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance. Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer. Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
18. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001 [TBL] [Abstract][Full Text] [Related]
19. [The correlation between stanniocalcin 2 expression and prognosis in laryngeal squamous cell cancer]. Zhang C; Guan Z; Peng J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):102-7. PubMed ID: 25989652 [TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study. Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]